Morgan Stanley’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.7M | Buy |
|
|||||
|
2025
Q1 | $17.4M | Sell |
|
|||||
|
2024
Q4 | $29.5M | Sell |
|
|||||
|
2024
Q3 | $42.2M | Sell |
|
|||||
|
2024
Q2 | $41.5M | Sell |
|
|||||
|
2024
Q1 | $37.2M | Sell |
|
|||||
|
2023
Q4 | $64.7M | Buy |
|
|||||
|
2023
Q3 | $1.99M | Buy |
|
|||||
|
2023
Q2 | $2.09M | Sell |
|
|||||
|
2023
Q1 | $2.25M | Sell |
|
|||||
|
2022
Q4 | $4.4M | Sell |
|
|||||
|
2022
Q3 | $6.26M | Sell |
|
|||||
|
2022
Q2 | $7.38M | Sell |
|
|||||
|
2022
Q1 | $9.54M | Buy |
|
|||||
|
2021
Q4 | $2.5M | Sell |
|
|||||
|
2021
Q3 | $4.18M | Sell |
|
|||||
|
2021
Q2 | $11.8M | Buy |
|
|||||
|
2021
Q1 | $2.92M | Buy |
|
|||||
|
2020
Q4 | $289K | Buy |
|
|||||
|
2020
Q3 | $60K | Buy |
|